Skip to content
Clinical Trials – home

St Vincent's University Hospital

Verified siteinfo

Ireland Elm Park Merrion Road, D04 T6F4 Dublin, Ireland

  • 46 trials recruiting
  • Breast cancer · Idiopathic pulmonary fibrosis · Breast cancer metastatic
  • Adults and children

About Specializations

St Vincent's University Hospital in Dublin, Ireland specialises in clinical trials of conditions such as Breast cancer, Idiopathic pulmonary fibrosis, Breast cancer metastatic, Colitis ulcerative, and other specialisations. This site conducts important research.

Main research areas of the site

Diseases and Nutritional and Metabolic Diseases

The Clinical Research Centre at St Vincent's University Hospital is conducting studies focused on obesity and related metabolic health concerns. This research area explores new ways to improve weight management and understand broader health risks linked to excess body weight.

  • Evaluating new therapies for overweight and obesity
  • Assessing cardiovascular safety in people with metabolic disease
  • Studying whether emerging treatments can improve long-term health outcomes

These trials are designed to test the effectiveness and safety of potential treatments, with a particular interest in reducing serious health complications associated with obesity.

Cardiometabolic Research

Clinical research at this site also examines how treatments for obesity may affect major cardiovascular outcomes. The work is aimed at understanding whether new options can support both weight-related care and protection against heart and blood vessel complications.

  • Investigating prevention of cardiovascular events in people with obesity
  • Comparing treatment effects on serious outcomes such as stroke and myocardial infarction
  • Supporting safer, more effective care for patients with metabolic disease

With a small but focused portfolio, St Vincent's University Hospital is contributing to research that may improve both metabolic health and long-term cardiovascular safety.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Elm Park Merrion RoadD04 T6F4 DublinIreland
Recruiting now
46 trials
Conditions studied
87
Partner status
Verified site

More sites in DublinIreland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

108 clinical trials

Cachexia

Recruiting

A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Visugromab
  • Sponsor:CatalYm GmbH

A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.

Breast cancer+1

Recruiting

Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.

Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm

Recruiting

Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant

Colorectal cancer+2

Recruiting

Study of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Revolution Medicines Inc.

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC

A study of tirzepatide and levonorgestrel in women with endometrial cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Levonorgestrel
  • Sponsor:University College Dublin

Comparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB

Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nintedanib
  • Sponsor:Avalyn Pharma Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.